The Independent spans critical themes ranging from reproductive rights to climate change and Big Tech, ensuring thorough investigative reporting during pivotal moments in U.S. history. Their commitment to accessible journalism without paywalls emphasizes their mission to inform all Americans, regardless of economic status. Meanwhile, Novo Nordisk's sales of the weight loss drug Wegovy soared over 86 percent in 2024, significantly boosting the company's value, although projections indicate a potential slowdown in future growth expected between 16 to 24 percent. The pharmaceutical giant credits its success to the growing demand for effective obesity treatments.
The strong sales of Wegovy and fellow weight loss treatment Ozempic helped the company's sales rise 26 per cent for the year, ahead of analyst predictions.
Novo Nordisk revealed that sales of Wegovy surged to 19.9 billion Danish kroner in the fourth quarter of last year, from 9.6 billion kroner a year earlier.
Collection
[
|
...
]